Growth Hormone (GH) Secretory Dynamics in a Case of Acromegalic Gigantism Associated with Hyperprolactinemia: Nonpulsatile Secretion of GH May Induce Elevated Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Levels

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 1, 1996, Pages 310-313

  Yoshida, Toshihide ^a   Shimatsu, Akira ^b   Sakane, Naoki ^a   Hizuka, Naomi ^c   Horikawa, Reiko ^d   Tanaka, Toshiaki ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE; GROWTH HORMONE; INSULIN; OCTREOTIDE; PROLACTIN; PROTIRELIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE INHIBITION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

ACROMEGALY; ADULT; GIGANTISM; GROWTH HORMONE; HUMANS; HYPERPROLACTINEMIA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROLACTIN;

EID: 0030025456     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.1.8550769     Document Type: Article

References (24)

1. Mims RB, Bethune JE. 1974 Acromegaly with fasting growth hormone concentrations but abnormal growth hormone regulation. Ann Intern Med. 81: 781-784.
2. Feingold KR, Goldfine ID, Weinstein PR. 1979 Acromegaly with normal growth-hormone levels and pituitary histology. J Neurosurg. 50:503-507.
3. Daughaday WH, Starkey RH, Saltman S, Gavin III JR, Millis-Dunlap B, Heath-Monnig E. 1987 Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of sertim GH. J Clin Endocrinol Metab. 65:617-623.
4. Pagesy P, Li JY, Rentier-Delrue F, et al. 1990 Growth hormone and somatostatin gene expression in pituitary adenomas with active acromegaly and minimal plasma growth hormone elevation. Acta Endocrinol (Copenh). 122: 745-752.
5. Brockmeier SJ, Buchfelder M, Adams EF, Schott W, Fahlbusch R. 1992 Acromegaly with "normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery. Horm Metab Res. 24:392-396.
6. Shimatsu A, Hattori N, Tanoh T, Assadian H, Imura H. 1990 Clinical application of a sensitive immunoradiometric assay for human growth hormone. Folia Endocrinol Jpn. 66:715-725.
7. Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG. 1980 A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab. 51: 1058-1063.
8. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardourin S, Binoux M. 1986 Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 154:138-143.
9. Carlsson LMS, Rowland AN, Clark RG, Gesundheit N, Wong WLT. 1991 Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood. J Clin Endocrinol Metab. 73:1216-1223.
10. Horikawa R, Tanaka T, Kokai Y, et al. 1994 Growth hormone-binding protein measurements in normal children and children with short statute using ligand-mediated immunofunctional assay. Clin Pediatr Endocrinol. 3:35-43.
11. Hattori N, Shimatsu A, Kato Y, Imura H. 1990 Growth hormone and growth hormone binding protein in human urine. Kidney Int. 37:951-954.
12. Hattori N, Shimatsu A, Kato Y, et al. 1990 Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intorelance and acromegaly. J Clin Endocrinol Metab. 70:771-776.
13. Mashiter K, Marco LD, Van Noorden S, et al. 1982 Inappropriately low serum GH in an acromegalic: lysosomal involvement in intracellular hormone degradation. Metabolism. 31:931-936.
14. Flyvbjerg A, Jorgensen KD, Marshall SM, Orskov H. 1991 Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. Am J Physiol. 260:E568-E574.
15. Serri O, Brazeau P, Kachra Z, Posner B. 1992 Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology. 130:1816-1821.
16. Bick T, Hochberg Z, Amit T, Isaksson OGP, Jansson J-O. 1992 Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH-receptors, and circulating GH-binding protein and insulin-like growth factor-I. Endocrinology. 131:423-429.
17. Jorgensen JOL, Moller N, Lauritzen T, Christiansen JS. 1990 Pulsatile versus continuous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices. J Clin Endocrinol Metab. 70:1616-1623.
18. Hartman ML, Veldhuis JD, Vance ML, Faria CS, Furlanetto RW, Thorner MO. 1990 Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab. 70:1375-1384.
19. Barkan AL, Beitins Z, Kelch RP. 1988 Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab. 67:69-73.
20. Giannella-Neto D, Wajchenberg BL, Mendonca BB, Almeida SF, Macchione M, Spencer EM. 1988 Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients. J Endocrinol Invest. 11:57-60.
21. Bistritzer T, Chalew SA, Lovchik JC, Kowarski AA. 1988 Growth without growth hormone: the "invisible" GH syndrome. Lancet. 1:321-323.
22. Clemmons DR, Underwood LE, Ridgway EC, Kliman B, van Wyk JJ. 1981 Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism. J Clin Endocrinol Metab. 52:731-735.
23. Valenta LJ, Elias AN. 1987 Clinical acromegaly with undetectable growth hormone and hyperprolactinemia. J Natl Med Ass. 79:555-560.
24. Campino C, Szecowka J, Lopez JM, Mulchahey J, Seron-Ferre M. 1992 Growth hormone (GH) receptor antibodies with GH-like activity occur spontaneously in acromegaly. J Clin Endocrinol Metab. 74:751-756.